Phathom Pharmaceuticals Q1 Net Loss Widens
08:52 AM EDT, 05/11/2021 (MT Newswires) -- Phathom Pharmaceuticals (PHAT) on Tuesday reported a Q1 net loss of $0.96 per diluted share, wider compared with the $0.62 loss a year earlier.
The drugmaker had cash and cash equivalents of $238 million as of the end of March, compared with $287.5 million as of Dec. 31, according to a statement.
The company didn't report any revenue during the quarter.
Analyst estimates weren't available
Price: 32.97, Change: -1.99, Percent Change: -5.69